Pipelines

HOME > R&D > Pipelines

Pipelines​

  Platform
Classification
Disease

Discovery

Pre-clinical

Clinical Trials

Collaborator
RNA & DDS[1]
COVID-19 (Vaccine)

Ongoing Phase 2a

Cancer (Vaccine)

DDS (LNP)

EYEGENE
NCE[2]
Blood Cancer(AML[3])

Solid Tumor (Glioblastoma)

Blood anticoagulant (NOAC[4])

Autism (ASD[5])

Solid Tumor (ovatian cancer, prostate cancer)

Solid Tumor (Cancer immunotherapy)

KRICT, KIRAMS, KAIST and SEVERANCE HOSPITAL, UNC, NeuroVenti, Seoul national University Bundang Hospital

KRICT, KIRAMS, KAIST and SEVERANCE HOSPITAL, UNC, NeuroVenti, Seoul national University Bundang Hospital, Redipharm, KYNOGEN

Redipharm

KYNOGEN

PROTAC[6]
Cancer

SaaS[7]
ADME/T

Newly started

(1) DDS (Drug Delivery System) (2) NCE (New Chemical Entity) (3) AML (Acute Myeloid Leukemia) (4) NOAC (New Oral Anticoagulant ) (5) ASD (Autism Spectrum Disorder) (6) PROTAC (PROteolysis Targeting Chimeras) (7) SaaS (Software as a Service)